User profiles for D. G. McArt

Darragh McArt

Queen's University Belfast
Verified email at qub.ac.uk
Cited by 7499

Digital pathology and image analysis in tissue biomarker research

…, Y Wang, R Hutchinson, D Kieran, DG McArt… - Methods, 2014 - Elsevier
Digital pathology and the adoption of image analysis have grown rapidly in the last few years.
This is largely due to the implementation of whole slide scanning, advances in software …

[HTML][HTML] QuPath: Open source software for digital pathology image analysis

…, JA Fernández, Y Dombrowski, DG McArt… - Scientific reports, 2017 - nature.com
QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly,
extensible, open-source solution for digital pathology and whole slide image analysis. …

[HTML][HTML] Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer

RA Hutchinson, RA Adams, DG McArt… - Journal of translational …, 2015 - Springer
The treatment of cancer is becoming more precise, targeting specific oncogenic drivers with
targeted molecular therapies. The epidermal growth factor receptor has been found to be …

Challenging the cancer molecular stratification dogma: intratumoral heterogeneity undermines consensus molecular subtypes and potential diagnostic value in …

PD Dunne, DG McArt, CA Bradley, PG O'Reilly… - Clinical Cancer …, 2016 - AACR
Purpose: A number of independent gene expression profiling studies have identified
transcriptional subtypes in colorectal cancer with potential diagnostic utility, culminating in …

EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer

PD Dunne, S Dasgupta, JK Blayney, DG McArt… - Clinical Cancer …, 2016 - AACR
Purpose: EphA2, a member of the Eph receptor tyrosine kinases family, is an important
regulator of tumor initiation, neovascularization, and metastasis in a wide range of epithelial and …

[HTML][HTML] Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational …

CM McCourt, DG McArt, K Mills, MA Catherwood… - PLoS …, 2013 - journals.plos.org
Next Generation Sequencing (NGS) has the potential of becoming an important tool in clinical
diagnosis and therapeutic decision-making in oncology owing to its enhanced sensitivity …

[HTML][HTML] Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer

P Bankhead, JA Fernández, DG McArt, DP Boyle… - Laboratory …, 2018 - Elsevier
Digital image analysis (DIA) is becoming central to the quantitative evaluation of tissue
biomarkers for discovery, diagnosis and therapeutic selection for the delivery of precision …

AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer

PD Dunne, DG McArt, JK Blayney, M Kalimutho… - Clinical Cancer …, 2014 - AACR
Purpose: Despite the use of 5-fluorouracil (5-FU)–based adjuvant treatments, a large
proportion of patients with high-risk stage II/III colorectal cancer will relapse. Thus, novel …

[HTML][HTML] Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification

…, PG Johnston, DB Longley, E Kay, DG McArt… - Nature …, 2017 - nature.com
Stromal-derived intratumoural heterogeneity (ITH) has been shown to undermine molecular
stratification of patients into appropriate prognostic/predictive subgroups. Here, using …

[HTML][HTML] Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy

…, GE Logan, AM McCavigan, D O'Rourke, DG McArt… - Annals of …, 2018 - Elsevier
Background Radiotherapy is an effective treatment of intermediate/high-risk locally advanced
prostate cancer, however, >30% of patients relapse within 5 years. Clinicopathological …